Successful hormonal and chemical induction of prostate cancer in a rat model: practical guidelines

Document Type : Review Article

Authors

1 Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

2 Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

3 LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal

4 Department of Zootechnics, School of Sciences and Technology, University of Évora, Évora, Portugal

5 Comprehensive Health Research Centre, Évora, Portugal

6 Animal and Veterinary Research Centre, Associate Laboratory for Animal and Veterinary Science (AL4AnimalS), University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

7 Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

8 Department of Zootechnics, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal

9 Departamento de Ciências Veterinárias, Escola de Ciências Agrárias e Veterinárias (ECAV), Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal

Abstract
Prostate cancer is a very common cancer in men, affecting approximately 1.40 million men worldwide in 2020. To improve the quality of life and survival of both animals and humans, effective therapeutic approaches have been developed and evaluated using animal models. The rat model of prostate cancer induced by a multi-step protocol that consists of a sequential administration of flutamide, followed by testosterone propionate, then the administration of N-methyl-N-nitrosourea, and finally subcutaneous implantation of tubes filled with crystalline testosterone, is one of the most frequently used for prostate cancer research. However, the lack of standardization in procedures for prostate cancer induction, sample collection, and analysis represents a challenge for researchers. To address this issue, we aim to provide investigators with a detailed, step-by-step guide to implementing a rat model of prostate cancer, based on our extensive experience in this field. First, we briefly review the prostate cancer-induced protocols found in the literature, then we provide a detailed description of the prostate cancer rat model implemented by our team. After, we explore the rats’ prostate monitoring during the experiment protocol through imaging modalities, such as ultrasonography, computed tomography, and magnetic resonance imaging. We also describe animal welfare monitoring based on a table of humane endpoints, as well as data collection, such as biological variables and prostate samples. In sum, this article will ensure the quality of results and enable their comparison among different researchers using this rat model.

Keywords

Subjects


  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3): 209-249.
  2. Cancer Today. International agency for research on cancer, WHO. Globocan 2020: Estimated cancer incidence, mortality and prevalence worldwide in 2020. Available at: http://gco.iarc.fr/today/home. Accessed Aug 18, 2023.
  3. Ericsson AC, Crim MJ, Franklin CL. A brief history of animal modeling. Mo Med 2013; 110(3): 201-205.
  4. Clarke R. Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 1996; 39(1): 1-6.
  5. Iannaccone PM, Jacob HJ. Rats! Dis Model Mech 2009; 2(5-6): 206-210.
  6. Liska J, Macejova D, Galbavy S, et al. Treatment of 1-methyl-1-nitrosourea-induced mammary tumours with immunostimulatory CpG motifs and 13-cis retinoic acid in female rats: histopathological study. Exp Toxicol Pathol 2003; 55(2-3): 173179.
  7. Report from the commission to the European parliament and the council 2019 report on the statistics on the use of animals for scientific purposes in the Member States of the European Union in 2015-2017. Brussels: European Commission; 2020: 21.
  8. Alvarado A, Faustino-Rocha AI, Colaço B, et al. Experimental mammary carcinogenesis - Rat models. Life Sci 2017;173: 116-134.
  9. Oliveira PA, Colaço A, Chaves R, et al. Chemical carcinogenesis. An Acad Bras Cienc. 2007; 79(4): 593-616.
  10. Knowles M, Selby P. Introduction to the cellular and molecular biology of cancer. 4th Oxford, UK: Oxford University Press 2005; 549.
  11. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21(3): 427-433.
  12. Arcos JC, Argus MF, Woo YT. Chemical induction of cancer: modulation and combination effects an inventory of the many factors which influence carcinogenesis. Boston, USA: Birkhäuser Boston; 1995; 711.
  13. Bosland MC, Schlicht MJ, Horton L, et al. The MNU plus testosterone rat model of prostate carcinogenesis. Toxicol Pathol 2022; 50(4): 478-496.
  14. Nascimento-Gonçalves E, Seixas F, Ferreira R, et al. An overview of the latest in state-of-the-art murine models for prostate cancer. Expert Opin Drug Discov 2021; 16(11): 1349-1364.
  15. Nascimento-Gonçalves E, Faustino-Rocha AI, Seixas F, et al. Modelling human prostate cancer: Rat models. Life Sci 2018; 203: 210224.
  16. Currier N, Solomon SE, Demicco EG, et al. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol 2005; 33(6): 726-737.
  17. Bonkhoff H, Remberger K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol 1993; 422(1): 35-38.
  18. Magee PN, Barnes JM. Carcinogenic nitroso compounds. Adv Cancer Res 1967; 10: 163-246.
  19. Singer B, Kuśmierek JT. Chemical mutagenesis. Ann Rev Biochem 1982; 51: 655-693.
  20. Shirai T, Takahashi S, Cui L, et al. Experimental prostate carcinogenesis - rodent models. Mutat Res 2000; 462(2-3): 219226.
  21. Bosland MC. Chemical and hormonal induction of prostate cancer in animal models. Urol Oncol 1996; 2(4): 103-110.
  22. Cekanova M, Rathore K. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther 2014; 8: 1911-1921.
  23. Shirai T. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention. Pathol Int 2008; 58(1): 1-16.
  24. Bosland MC. Animal models for the study of prostate carcinogenesis. J Cell Biochem Suppl 1992; 50(16H): 89-98.
  25. Lucia MS, Bostwick DG, Bosland M, et al. Workgroup I: rodent models of prostate cancer. Prostate. 19980; 36(1): 49-55.
  26. Nascimento-Goncalves E, Seixas F, DA Costa RMG, et al. Appraising animal models of prostate cancer for translational research: future directions. Anticancer Res 2023; 43(1): 275-281.
  27. Fautino-Rocha AI, Seixas F, Ferreira R, et al. Ultrasonographic follow-up of the multistep protocol for prostate cancer induction in wistar rats. In Vivo 2020; 34(4): 1797-1803.
  28. Ginja M, Pires MJ, Gonzalo-Orden JM, et al. Anatomy and imaging of rat prostate: practical monitoring in experimental cancer-induced protocols. Diagnostics (Basel) 2019; 9(3): 68. doi: 10.3390/diagnostics9030068.
  29. Denis F, Bougnoux P, de Poncheville L, et al. In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumors. Ultrasound Med Biol 2002; 28(4): 431437.
  30. Faustino-Rocha AI, Gama A, Oliveira PA, et al. Effects of lifelong exercise training on mammary tumorigenesis induced by MNU in female Sprague-Dawley rats. Clin Exp Med 2017; 17(2): 151-160.
  31. Faustino-Rocha AI, Ginja M, Ferreira R, et al. Studying humane endpoints in a rat model of mammary carcinogenesis. Iran J Basic Med Sci 2019; 22(6): 643-649.
  32. Arantes-Rodrigues R, Henriques A, Pires MJ, et al. High doses of olive leaf extract induce liver changes in mice. Food Chem Toxicol 2011; 49(9): 1989-1997.
  33. Talhada D, Andrade A, Faustino-Rocha AI, et al. Recommendations for urine and urinary bladder collection in chemical carcinogenesis assays with rodents. Scand J Lab Anim Sci 2015; 41: 1-8.
  34. Bosland MC, Tuomari DL, Elwell MR, et al. Proliferative lesions of the prostate and other accessory sex glands in male rats. In: Guides for toxicologic pathology. Washington DC, USA: STP/ARP/AFIP 1998; 1-20.
Volume 15, Issue 9
September 2024
Pages 445-453

  • Receive Date 02 April 2023
  • Accept Date 17 June 2023